These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14971804)

  • 21. Children's perceptions about medicines: individual differences and taste.
    Mennella JA; Roberts KM; Mathew PS; Reed DR
    BMC Pediatr; 2015 Sep; 15():130. PubMed ID: 26391354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Tuleu C
    Drugs; 2014 Oct; 74(16):1871-1889. PubMed ID: 25274536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept.
    Mooij MG; van Duijn E; Knibbe CA; Windhorst AD; Hendrikse NH; Vaes WH; Spaans E; Fabriek BO; Sandman H; Grossouw D; Hanff LM; Janssen PJ; Koch BC; Tibboel D; de Wildt SN
    Clin Pharmacokinet; 2014 Nov; 53(11):1045-51. PubMed ID: 25227283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid oral forms availability in children: a cost saving investigation.
    Lajoinie A; Henin E; Kassai B; Terry D
    Br J Clin Pharmacol; 2014 Nov; 78(5):1080-9. PubMed ID: 24965935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Status of Pediatric Labeling in China and the near Future Efforts Needed for the Country.
    Li Z; Wang Y; Wu D; Gao X; Wang Z
    Front Pediatr; 2014; 2():17. PubMed ID: 24724075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance for children's sake.
    Star K; Edwards IR
    Drug Saf; 2014 Feb; 37(2):91-8. PubMed ID: 24446277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving antibiotic prescribing for children in the resource-poor setting.
    Le Doare K; Barker CI; Irwin A; Sharland M
    Br J Clin Pharmacol; 2015 Mar; 79(3):446-55. PubMed ID: 24433393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bad taste of medicines: overview of basic research on bitter taste.
    Mennella JA; Spector AC; Reed DR; Coldwell SE
    Clin Ther; 2013 Aug; 35(8):1225-46. PubMed ID: 23886820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to improve the implementation of academic clinical pediatric trials involving drug therapy? A qualitative study of multiple stakeholders.
    Girard D; Bourdon O; Abdoul H; Prot-Labarthe S; Brion F; Tibi A; Alberti C
    PLoS One; 2013; 8(5):e64516. PubMed ID: 23724056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.
    Roth WJ; Kissinger CB; McCain RR; Cooper BR; Marchant-Forde JN; Vreeman RC; Hannou S; Knipp GT
    AAPS J; 2013 Jul; 15(3):763-74. PubMed ID: 23595360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing.
    Mukattash TL; Wazaify M; Khuri-Boulos N; Jarab A; Hawwa AF; McElnay JC
    Int J Clin Pharm; 2011 Dec; 33(6):964-73. PubMed ID: 21952953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose variations associated with formulations of NSAID prescriptions for children: a descriptive analysis of electronic health records in the UK.
    Star K; Caster O; Bate A; Edwards IR
    Drug Saf; 2011 Apr; 34(4):307-17. PubMed ID: 21417503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three years of paediatric regulation in the European Union.
    Olski TM; Lampus SF; Gherarducci G; Saint Raymond A
    Eur J Clin Pharmacol; 2011 Mar; 67(3):245-52. PubMed ID: 21286912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007.
    Ragupathy R; Tordoff J; Norris P; Reith D
    Pharm World Sci; 2010 Jun; 32(3):386-93. PubMed ID: 20354788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals.
    Marchetti F; Bua J; Ventura A; Notarangelo LD; Di Maio S; Migliore G; Bonati M
    Eur J Clin Pharmacol; 2007 Jan; 63(1):81-5. PubMed ID: 17124577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002.
    Balakrishnan K; Tordoff J; Norris P; Reith D
    Br J Clin Pharmacol; 2007 Jan; 63(1):85-91. PubMed ID: 16869822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When do children convert from liquid antiretroviral to solid formulations?
    Yeung VW; Wong IC
    Pharm World Sci; 2005 Oct; 27(5):399-402. PubMed ID: 16341747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of appropriate formulations of medicines for children in the community.
    Schirm E; Tobi H; de Vries TW; Choonara I; De Jong-van den Berg LT
    Acta Paediatr; 2003 Dec; 92(12):1486-9. PubMed ID: 14971804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.